Find similar content

Source channel @githubtrending · Post #14680 · May 7

#go#backend#backend_as_a_service#chat_server#game_backend#game_framework#game_server#multiplayer#nakama#realtime#realtime_games#social#unity_engine#unreal_engine Nakama is an open-source, scalable server for building social and real-time multiplayer games and apps. It offers features like user accounts, social connections, chat, multiplayer matchmaking, leaderboards, tournaments, and in-app purchase validation. You can extend it with custom code in Lua, JavaScript, or Go. Nakama supports multiple platforms and protocols, making it easy to integrate with popular game engines. It includes a web console for managing player data and game metrics. You can run Nakama locally with Docker or deploy it on any cloud provider. This helps you quickly build and scale games with ready-made backend services, saving time and effort. https://github.com/heroiclabs/nakama

Hashtags

#go #backend #backend_as_a_service #chat_server #game_backend #game_framework #game_server #multiplayer #nakama #realtime #realtime_games #social #unity_engine #unreal_engine

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment